- Home
- AZN vs GS Comparison
AZN vs GS Comparison
Compare AZN & GS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZN
- GS
- Stock Information
- Founded
- AZN 1992
- GS 1869
- Country
- AZN United Kingdom
- GS United States
- Employees
- AZN N/A
- GS N/A
- Industry
- AZN Biotechnology: Pharmaceutical Preparations
- GS Investment Bankers/Brokers/Service
- Sector
- AZN Health Care
- GS Finance
- Exchange
- AZN Nasdaq
- GS Nasdaq
- Market Cap
- AZN 228.9B
- GS 187.7B
- IPO Year
- AZN 1993
- GS 1999
- Fundamental
- Price
- AZN $69.95
- GS $640.91
- Analyst Decision
- AZN Strong Buy
- GS Buy
- Analyst Count
- AZN 3
- GS 15
- Target Price
- AZN $95.00
- GS $602.54
- AVG Volume (30 Days)
- AZN 4.0M
- GS 1.8M
- Earning Date
- AZN 07-24-2025
- GS 07-16-2025
- Dividend Yield
- AZN 2.21%
- GS 1.87%
- EPS Growth
- AZN 22.71
- GS 68.40
- EPS
- AZN 4.97
- GS 42.98
- Revenue
- AZN $54,982,000,000.00
- GS $53,044,000,000.00
- Revenue This Year
- AZN $9.56
- GS $9.36
- Revenue Next Year
- AZN $6.09
- GS $4.33
- P/E Ratio
- AZN $14.05
- GS $14.91
- Revenue Growth
- AZN 15.48
- GS 13.52
- 52 Week Low
- AZN $61.24
- GS $437.37
- 52 Week High
- AZN $87.68
- GS $672.19
- Technical
- Relative Strength Index (RSI)
- AZN 42.41
- GS 68.17
- Support Level
- AZN $72.18
- GS $609.59
- Resistance Level
- AZN $75.38
- GS $632.27
- Average True Range (ATR)
- AZN 1.03
- GS 10.85
- MACD
- AZN -0.36
- GS 0.84
- Stochastic Oscillator
- AZN 5.07
- GS 96.56
About AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
About GS Goldman Sachs Group Inc. (The)
Goldman Sachs is a leading global investment banking and asset management firm. Approximately 14% of its revenue comes from investment banking, 42% from trading, 20% from asset & wealth management, 15% from net interest income, and 9% from other principal transactions. Around 64% of the company's net revenue is generated in the Americas, 13% in Asia, and 23% in Europe, the Middle East, and Africa.